Open AccessRanibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis
Author(s) -
Yufei Tu,
Catherine Fay,
Suqin Guo,
Marco A. Zarbin,
Edward Marcus,
Neelakshi Bhagat
Publication year - 2012
Publication title -
oman journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.306
H-Index - 16
eISSN - 0974-7842
pISSN - 0974-620X
DOI - 10.4103/0974-620x.106099
Subject(s) - medicine , ranibizumab , diabetic retinopathy , cataract surgery , ophthalmology , adverse effect , choroidal neovascularization , surgery , retinal , bevacizumab , diabetes mellitus , chemotherapy , endocrinology
To evaluate the safety of ranibizumab as a surgical adjunct during cataract surgery in patients with proliferative diabetic retinopathy (PDR) with rubeosis, and to evaluate the efficacy and adverse effects of ranibizumab in treating PDR with rubeosis.